These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An overview of constipation and newer therapies. Enck RE Am J Hosp Palliat Care; 2009; 26(3):157-8. PubMed ID: 19531698 [No Abstract] [Full Text] [Related]
3. Emerging new therapeutic options for the management of opioid induced constipation. Kapoor S J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):98-9. PubMed ID: 20345211 [No Abstract] [Full Text] [Related]
4. Methylnaltrexone for the Treatment of Constipation in Critically Ill Children. López J; Fernández SN; Santiago MJ; Urbano J; González R; Fernández-Llamazares C; López-Herce J J Clin Gastroenterol; 2016 Apr; 50(4):351-2. PubMed ID: 26950234 [No Abstract] [Full Text] [Related]
5. Methylnaltrexone for opioid-induced constipation in advanced illness. Sanz Rubiales A; del Valle Rivero ML N Engl J Med; 2008 Sep; 359(10):1070-1; author reply 1071. PubMed ID: 18768955 [No Abstract] [Full Text] [Related]
6. Opioid side effects--mechanism-based therapy. Berde C; Nurko S N Engl J Med; 2008 May; 358(22):2400-2. PubMed ID: 18509126 [No Abstract] [Full Text] [Related]
7. Current concepts in the management of opioid-induced constipation: a perfect review with an imperfect concept. Ruan X J Opioid Manag; 2011; 7(3):167, 170; author reply 170-2. PubMed ID: 21823547 [No Abstract] [Full Text] [Related]
8. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review. Leppert W Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006 [TBL] [Abstract][Full Text] [Related]
10. Management of constipation in patients receiving palliative care. Cayley WE Am Fam Physician; 2011 Dec; 84(11):1227-8. PubMed ID: 22150655 [No Abstract] [Full Text] [Related]
11. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal? Holzer P Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544 [TBL] [Abstract][Full Text] [Related]
12. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction. Baker DE Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269 [TBL] [Abstract][Full Text] [Related]
13. Subsidised use of methylnaltrexone in Australia for palliative care. Rowett DS; Clark K; Robinson MK; Currow DC Med J Aust; 2012 Nov; 197(9):492. PubMed ID: 23121581 [No Abstract] [Full Text] [Related]
18. The role of methylnaltrexone in opioid-induced constipation. Hellwig TR; Pottebaum AA S D Med; 2013 Oct; 66(10):425, 427. PubMed ID: 24244983 [No Abstract] [Full Text] [Related]
19. The Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipation. Lang L Gastroenterology; 2008 Jul; 135(1):6. PubMed ID: 18549816 [No Abstract] [Full Text] [Related]